API 0.74% $1.35 australian pharmaceutical industries limited

News was built in to the rapid SP escalation already seen. I'm...

  1. 2,000 Posts.
    lightbulb Created with Sketch. 27
    News was built in to the rapid SP escalation already seen. I'm surprised the SP hasnt weakened more as the current result is as forecast, ie no upside surprise. A 2c divvy and no great expectation of further dramatic improvements means there is no compelling reason to buy into API at this time.
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.